Anti-nuclear and anti-cytoplasmic antibodies (ANA2)

Clinical significance:

Test useful in the diagnosis of many autoimmune diseases, especiallyrheumatic diseases, and such as:

• systemic lupus erythematosus (SLE),
• drug-induced lupus erythematosus,
• mixed connective tissue disease (MCTD),
• Sjogren's syndrome,
• progressive systemic scleroderma (PSS),
• multimuscular (PM) and skrno-muscular (DM) inflammation,
• autoimmune hepatitis (AIH),
• primary drgitis (PBC),